Media and Press

Roger E. Rönn, Founder and CEO of Sorbus Biomedical presenting at the Global Forum 2024 by BioStock
Nordic Life Science Days 2023: BioStock – Connecting Innovation and Capital met up with Roger E. Rönn, Founder and CEO of Sorbus Biomedical – a SmiLe Venture Hub startup.

PRESS RELEASE 29- 08- 2022

Revolutionary technology for cell handling receives continued support from Sten K Johnson

Lund, Sweden – Deep Tech company Sorbus Biomedical, a member of SmiLe Incubator in Lund, has been awarded a grant by the Sten K Johnson Foundation for its project “Evaluation of prototype equipment for expansive culturing of clinically relevant cells.” The grant will provide new opportunities to test the company’s innovative equipment, which by restoring the natural environment of the cells makes it possible to produce and work with healthier and more valuable cells.

For full article click here

PRESS RELEASE 24- 08- 2021

Cellodling utvecklas med stipendium från Sten K Johnsons Stiftelse

Roger Rönn, vd för Sorbus Biomedical, har tilldelats stipendium från Sten K Johnsons Stiftelse för bolagets projekt ”Utrustning för odling av celler med ökad funktion och applikationspotential”. Stipendiet har stor betydelse för att stödja bolagets fortsatta utveckling av en upptäckt som kan komma att medföra ett paradigmskifte inom cellodling. Sorbus Biomedical är medlem i SmiLe Incubator.

For full article click here
Video from 1- 05- 2018: in this webcast, hosted by BioLamina, our CEO Dr. Roger Rönn presents his research on how to make blood from human pluripotent stem cells using laminins and hypoxic conditions. Here it can be seen how reaching physiological conditions – wich varies from cell to cell in our body – is important in order to achieve the optimal results.